MyCannabis is a subsidiary of Avicanna Inc., which is a leading Canadian biotechnology company focused on innovative advancements in the medical cannabis industry worldwide. Through its multi-level and multi-market strategic approach and the support of its world-class academic partnerships, Avicanna has developed its pipeline of cannabinoid-based products using advanced delivery mechanisms and formulations. Avicanna Inc., is a JLABS @ Toronto resident (Johnson & Johnson) and is the only cannabinoid related company in Toronto’s MaRS discovery district